---
title: "CCGB issued a preliminary increase, expecting the net profit attributable to the parent company for the first three quarters to be between 278 million yuan and 314 million yuan, an increase of 344.05% to 401.55%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260874350.md"
description: "CCGB expects the net profit attributable to shareholders for the first three quarters of 2025 to be between 278 million yuan and 314 million yuan, a year-on-year increase of 344.05% to 401.55%. The net profit after deducting non-recurring gains and losses is expected to be between 218 million yuan and 254 million yuan, a year-on-year increase of 1398.00% to 1645.38%. The main revenue and gross profit growth from plant extraction products, along with the cottonseed business turning profitable, have significantly boosted overall performance"
datetime: "2025-10-13T10:06:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260874350.md)
  - [en](https://longbridge.com/en/news/260874350.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260874350.md)
---

# CCGB issued a preliminary increase, expecting the net profit attributable to the parent company for the first three quarters to be between 278 million yuan and 314 million yuan, an increase of 344.05% to 401.55%

According to the Zhitong Finance APP, CCGB (300138.SZ) disclosed its performance forecast for the first three quarters of 2025. The company expects a net profit attributable to shareholders of the listed company to be between 278 million yuan and 314 million yuan, a year-on-year increase of 344.05% to 401.55%; the net profit after deducting non-recurring gains and losses is expected to be between 218 million yuan and 254 million yuan, a year-on-year increase of 1398.00% to 1645.38%.

In the first three quarters of 2025, the revenue and gross profit of major plant extraction products increased year-on-year, and profitability recovered; the cottonseed business saw a market rebound, significantly improving the operating environment, achieving a turnaround from loss to profit year-on-year, and the company's overall performance increased compared to the same period last year

### Related Stocks

- [300138.CN](https://longbridge.com/en/quote/300138.CN.md)

## Related News & Research

- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [15:30 ETTravis Manion Foundation to Honor 10,000 Military Heroes on Memorial Day Weekend Through "The Honor Project"](https://longbridge.com/en/news/287109444.md)
- [PRECIOUS-Gold falls to 1-1/2-month low on higher US yields, firm dollar](https://longbridge.com/en/news/287016248.md)
- [PRECIOUS-Gold eases as higher yields, firm dollar offset US-Iran peace hopes](https://longbridge.com/en/news/286996403.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)